申请人:Novo Nordisk A/S
公开号:US05284847A1
公开(公告)日:1994-02-08
Novel thieno[2,3-b]pyrazine-2,3(1H,3H)-diones or tautomeric forms thereof of the formula (I) ##STR1## The compounds are useful in the treatment of neurological and psychiatric diseases.
新型噻吩并[2,3-b]吡嗪-2,3(1H,3H)-二酮或其互变异构体的化学式(I)如下:##STR1## 这些化合物在治疗神经系统和精神疾病方面具有用途。